Fetal nucleic acids in maternal plasma: from biology to clinical translation

Neha Bunkar1, Arpit Bhargava2, Koel Chaudhury3

  • 1Translational Research Laboratory, School of Biological Sciences, Dr. Harisingh Gour Central University, Sagar, India.

Insights

Environmental contaminants disrupt fetal development by altering genetic and epigenetic programming. Analyzing cell-free fetal nucleic acids in maternal blood shows promise for detecting environmentally-linked fetal abnormalities.

Area of Science:

  • Environmental health
  • Prenatal diagnostics
  • Molecular biology

Background:

  • Pregnancy exposure to environmental contaminants can disrupt fetal growth and programming.
  • These disruptions can lead to immediate, lifelong, or transgenerational developmental disorders.
  • Cell-free fetal nucleic acids in maternal plasma offer insights into fetal development.

Purpose of the Study:

  • To review the utility of cell-free fetal nucleic acids as biomarkers for environmentally-associated fetal abnormalities.
  • To discuss advancements in fetal nucleic acid analysis and quantification.
  • To explore challenges and applications in fetomaternal medicine.

Main Methods:

  • Literature review of studies on environmental contaminants and fetal development.
  • Analysis of research on cell-free fetal nucleic acids in maternal plasma.
  • Discussion of current and emerging methodologies for fetal nucleic acid detection.

Main Results:

  • Cell-free fetal nucleic acids reflect in utero cellular changes, indicating normal or abnormal fetal development.
  • These nucleic acids hold potential for developing biomarkers for screening environmental exposures.
  • Recent advancements are improving analysis and quantification, though challenges remain.

Conclusions:

  • Cell-free fetal nucleic acids are valuable tools for monitoring fetal health in the context of environmental exposures.
  • Further research and technological development are needed to fully realize their potential in prenatal screening.
  • These biomarkers could revolutionize fetomaternal medicine for early detection of environmental impacts.